Orchard Therapeutics Receives EC Approval for Treatment of Early-Onset Metachromatic Leukodystrophy

Appointment of Professor Akiko Iwasaki to Scientific Advisory Board

ADC Therapeutics Announces FDA’s Acceptance of its Biologics License Application

4BIO Capital invests in Araris Biotech AG’s CHF 15.2 million seed financing round

4BIO Capital leads SparingVision’s €44.5 million financing round

4BIO Capital announces appointment of Professor Kenya Honda to Scientific Advisory Board